Cargando…

Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?

BACKGROUND: In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational research. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radzina, Maija, Saule, Laura, Mamis, Edgars, Koester, Ulli, Cocolios, Thomas Elias, Pajuste, Elina, Kalnina, Marika, Palskis, Kristaps, Sawitzki, Zoe, Talip, Zeynep, Jensen, Mikael, Duchemin, Charlotte, Leufgen, Kirsten, Stora, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570248/ https://www.ncbi.nlm.nih.gov/pubmed/37823964 http://dx.doi.org/10.1186/s41181-023-00211-5

Ejemplares similares

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Nanoparticles in the environment: where do we come from, where do we go to?
por: Bundschuh, Mirco, et al.
Publicado: (2018)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Where Do We Stand?
Publicado: (1891)

Psychopharmacology Today: Where are We and Where Do We Go From Here?
por: Schwartz, Thomas L.
Publicado: (2010)

Health Psychology: Where Are We And Where Do We Go From Here?
por: Kaplan, Robert M.
Publicado: (2009)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Precision medicine in COPD: where are we and where do we need to go?
por: Sidhaye, Venkataramana K., et al.
Publicado: (2018)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Dermatology education in skin of colour: where we are and where do we go?
por: Onasanya, Joshua, et al.
Publicado: (2021)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
por: Werner, Rudolf A., et al.
Publicado: (2018)

Selenium, Stroke, and Infection: A Threefold Relationship; Where Do We Stand and Where Do We Go?
por: Liampas, Andreas, et al.
Publicado: (2023)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
por: Eichenauer, Dennis A., et al.
Publicado: (2023)

Access to Healthcare Interpreter Services: Where Are We and Where Do We Need to Go?
por: Bischoff, Alexander, et al.
Publicado: (2010)

Communication skills in medicine: where do we come from and where are we going?
por: Ferreira-Padilla, Guillermo, et al.
Publicado: (2015)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Utilizing proteomics to understand and define hypertension: where are we and where do we go?
por: Delles, Christian, et al.
Publicado: (2018)

Antibiotic Discovery: Where Have We Come from, Where Do We Go?
por: Ribeiro da Cunha, Bernardo, et al.
Publicado: (2019)

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
por: Hasenoehrl, Carina, et al.
Publicado: (2017)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
por: Laine, Christopher G., et al.
Publicado: (2020)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022)

STI management and control in Latin America: where do we stand and where do we go from here?
por: Garcia, Patricia J, et al.
Publicado: (2011)

Stem Cell Therapy in Bladder Dysfunction: Where Are We? And Where Do We Have to Go?
por: Kim, Jae Heon, et al.
Publicado: (2013)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
por: Banz-Jansen, Constanze, et al.
Publicado: (2022)

Coronavirus (COVID-19) and Stress: Where Do We Stand in This Journey and Where Are We Leading to!
por: Avinash, Bhagyalakshmi, et al.
Publicado: (2022)

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
por: Harari, Sergio, et al.
Publicado: (2015)

Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
por: do Carmo Silva, Lívia, et al.
Publicado: (2020)

Pixel Detectors ... where do we stand?
por: Wermes, Norbert
Publicado: (2019)

Laser accelerators : where do we stand
por: Lawson, J D
Publicado: (1985)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012)

WHERE DO WE GO FROM HERE?
por: Kuruvilla, K.
Publicado: (1994)

LHC Access - Where do we Stand
por: Ninin, P, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_2doc92r073t60ac6bmlljb0pgc